Indraprastha Medical Corporation Limited (BOM:532150)
India flag India · Delayed Price · Currency is INR
419.05
-12.65 (-2.93%)
At close: Feb 13, 2026

BOM:532150 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
14,51513,56412,44710,9878,8826,134
Revenue Growth (YoY)
8.53%8.97%13.29%23.70%44.80%-26.17%
Cost of Revenue
5,7655,2785,0404,6304,0593,257
Gross Profit
8,7508,2867,4076,3574,8232,877
Selling, General & Admin
876.5876.51,066894.6552.1284.5
Other Operating Expenses
5,1914,9614,3963,9473,0702,182
Operating Expenses
6,4996,2815,8635,2343,9722,800
Operating Income
2,2512,0051,5451,123851.376.6
Interest Expense
-27.8-30.3-10.6-4.6-6.1-
Interest & Investment Income
226.5226.5168.9100.331.26.8
Other Non Operating Income (Expenses)
18.8-32.4-30-38.2-28-33.4
EBT Excluding Unusual Items
2,4682,1681,6731,181848.450
Gain (Loss) on Sale of Assets
-5.2-5.2-11.7-8.7-57.7-7.1
Pretax Income
2,4632,1631,6611,172790.742.9
Income Tax Expense
633.5553.3421.5310.3204.519.6
Net Income
1,8291,6101,240861.5586.223.3
Net Income to Common
1,8291,6101,240861.5586.223.3
Net Income Growth
21.02%29.87%43.89%46.96%2415.88%-94.66%
Shares Outstanding (Basic)
929292929292
Shares Outstanding (Diluted)
929292929292
EPS (Basic)
19.9517.5613.529.406.390.25
EPS (Diluted)
19.9517.5613.529.406.390.25
EPS Growth
20.98%29.88%43.87%47.07%2456.00%-94.75%
Free Cash Flow
-1,2041,308998.9648.258.5
Free Cash Flow Per Share
-13.1414.2610.907.070.64
Dividend Per Share
-4.5004.5003.0002.500-
Dividend Growth
--50.00%20.00%--
Gross Margin
60.28%61.09%59.51%57.86%54.30%46.90%
Operating Margin
15.50%14.78%12.41%10.22%9.59%1.25%
Profit Margin
12.60%11.87%9.96%7.84%6.60%0.38%
Free Cash Flow Margin
-8.88%10.51%9.09%7.30%0.95%
EBITDA
2,6802,4051,9071,4771,160371
EBITDA Margin
18.46%17.73%15.32%13.44%13.06%6.05%
D&A For EBITDA
429.13400.7362.8354308.3294.4
EBIT
2,2512,0051,5451,123851.376.6
EBIT Margin
15.50%14.78%12.41%10.22%9.59%1.25%
Effective Tax Rate
25.72%25.58%25.37%26.48%25.86%45.69%
Revenue as Reported
14,79213,79012,61611,0878,9136,141
Source: S&P Global Market Intelligence. Standard template. Financial Sources.